TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $597,096 | -81.6% | 71,423 | -45.4% | 0.01% | -83.1% |
| Q2 2023 | $3,246,439 | +78.6% | 130,694 | +8.1% | 0.07% | +61.4% |
| Q1 2023 | $1,818,140 | +21.5% | 120,887 | -4.4% | 0.04% | +4.8% |
| Q4 2022 | $1,495,809 | +188.8% | 126,442 | +1075.5% | 0.04% | +82.6% |
| Q1 2021 | $518,000 | -70.5% | 10,756 | -68.1% | 0.02% | -60.3% |
| Q4 2020 | $1,754,000 | +94.5% | 33,716 | +0.0% | 0.06% | +100.0% |
| Q3 2020 | $902,000 | +3.4% | 33,700 | -24.8% | 0.03% | +11.5% |
| Q2 2020 | $872,000 | +1306.5% | 44,788 | +303.3% | 0.03% | +2500.0% |
| Q3 2019 | $62,000 | – | 11,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |